SCHEMBL31455672

SCHEMBL31455672

C=Cc1cccc(CC(=O)OC)c1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.35
EGFR P00533 2/20 0.35
CYP4F2 P78329 1/20 0.35
CYP4A11 Q02928 1/20 0.35
CFD P00746 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
TSHR P16473 1/20 0.34
SLC7A5 Q01650 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
NFE2L2 Q16236 1/20 0.33
MTNR1A P48039 1/20 0.33
MTNR1B P49286 1/20 0.33
HSP90AB1 P08238 1/20 0.33
MEN1 O00255 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
LMNA P02545 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GLA P06280 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5283277 0.84 KDM4E (0.43) KDM4ESMN1; SMN2EGFRCYP4F2CYP4A11
SCHEMBL24736066 0.83 KDM4E (0.41) KDM4ESMN1; SMN2EGFRCYP4F2CYP4A11
SCHEMBL4370866 0.81 CA12 (0.42) KDM4ESMN1; SMN2EGFRCYP4F2CYP4A11
SCHEMBL6826872 0.81 KDM4E (0.39) KDM4ESMN1; SMN2EGFRCYP4F2CYP4A11
SCHEMBL506923 0.79 SMN1; SMN2 (0.46) KDM4ESMN1; SMN2CYP4F2CYP4A11HTT
SCHEMBL29907828 0.79 SMN1; SMN2 (0.47) KDM4ESMN1; SMN2EGFRL3MBTL1TSHR
SCHEMBL23270686 0.79 SMN1; SMN2 (0.47) KDM4ESMN1; SMN2EGFRL3MBTL1TSHR
SCHEMBL2972991 0.78 MEP1B (0.48) KDM4ESMN1; SMN2EGFRCYP4F2CYP4A11
SCHEMBL16950364 0.77 GABRA1 (0.40) MEN1KMT2AALDH1A1
SCHEMBL18261999 0.76 KDM4E (0.43) KDM4ESMN1; SMN2EGFRCYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059562-A1 SUBSTITUTED AMINOPYRIDINE COMPOUNDS AND METHODS OF TREATING DISEASE USING SAME ATAVISTIK BIO, INC. (US) 2025-03-20 WO disclosed